从“治未病”理论治疗原发性肝癌的概述

An Overview of Treating Primary Liver Cancer from the Perspective of “Preventive Treatment of Disease”

摘要: 原发性肝癌是一种备受关注的恶性肿瘤，其高发病率、高死亡率及快速的病程进展对人类健康构成了严重威胁。中医“治未病”理论源远流长，来源于《黄帝内经》。随着“治未病”思想的广泛传播与应用，越来越多的研究显示其在预防和治疗原发性肝癌方面具有独特优势。文章将深入探讨“治未病”理论在原发性肝癌的防治与治疗中的运用，并展示中医药在原发性肝癌治疗方面的重要作用。通过运用“治未病”理论，旨在减少原发性肝癌的发病与复发风险，为医学领域作出贡献。

Abstract: Primary liver cancer (HCC) is a kind of malignant tumor that attracts much attention. Its high incidence, high mortality, and rapid progression pose a serious threat to human health. The theory of “preventive treatment of disease” in traditional Chinese medicine has a long history, which comes from the “Huangdi Neijing” (Inner Canon of the Yellow Emperor). With the widespread dissemination and application of the idea of “preventive treatment of disease”, more and more studies show that it has unique advantages in the prevention and treatment of primary liver cancer. This article will deeply discuss the application of the theory of “preventive treatment of disease” in the prevention and treatment of primary liver cancer and demonstrate the important role of traditional Chinese medicine in the treatment of primary liver cancer. By applying the theory of “preventive treatment of disease”, the aim is to reduce the risk of primary liver cancer occurrence and recurrence and make contributions to the medical field.